Urología
Especialidad
![Foto de Urología](/img/noimage.png)
![Foto de Hospital Clínico San Carlos de Madrid](/img/noimage_org.png)
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (14)
2024
-
Prevalence of urinary tract cancer in the Spanish cohort of the IDENTIFY study
Actas Urologicas Espanolas, Vol. 48, Núm. 3, pp. 228-237
2023
-
A multidisciplinary consensus statement on the optimal pharmacological treatment for metastatic hormone-sensitive prostate cancer
Actas Urologicas Espanolas, Vol. 47, Núm. 2, pp. 111-126
-
Abiraterone in low-volume metastatic hormone-sensitive prostate cancer. Authors’ reply
Actas Urologicas Espanolas
-
Impact of a delayed presentation to the emergency department for acute renal colic on biochemical and clinical outcomes
Actas Urologicas Espanolas, Vol. 47, Núm. 1, pp. 41-46
2022
-
Recommendations on the use of intravesical hyaluronic acid instillations in bladder pain syndrome
Actas Urologicas Espanolas, Vol. 46, Núm. 3, pp. 131-137
2020
-
El impacto del COVID-19 en la residencia en urología en España: perspectivas y recomendaciones
Archivos espanoles de urologia, Vol. 73, Núm. 5, pp. 471-478
-
Manejo del paciente neurourológico durante la pandemia COVID-19
Archivos espanoles de urologia, Vol. 73, Núm. 5, pp. 429-437
2015
-
Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013
European Urology, Vol. 68, Núm. 2, pp. 256-262
-
Sequential combination of mitomycin C plus bacillus calmette-guérin (BCG) is more effective but more toxic than BCG alone in patients with non-muscle-invasive bladder cancer in intermediate- and high-risk patients: Final outcome of CUETO 93009, a randomized prospective trial
European Urology, Vol. 67, Núm. 3, pp. 508-516
2014
-
Evaluación de las propiedades psicométricas de la versión en español del cuestionario ICIQ-Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) en España
Actas Urologicas Espanolas, Vol. 38, Núm. 2, pp. 71-77
2013
-
Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572
2011
2009
-
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model
Journal of Urology, Vol. 182, Núm. 5, pp. 2195-2203
2008
-
Prognostic Factors in Patients with Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials
European Urology, Vol. 53, Núm. 5, pp. 992-1002